344 related articles for article (PubMed ID: 24692095)
1. Dried blood spots: concepts, present status, and future perspectives in bioanalysis.
Sharma A; Jaiswal S; Shukla M; Lal J
Drug Test Anal; 2014 May; 6(5):399-414. PubMed ID: 24692095
[TBL] [Abstract][Full Text] [Related]
2. Clinical feasibility of dried blood spots: Analytics, validation, and applications.
Enderle Y; Foerster K; Burhenne J
J Pharm Biomed Anal; 2016 Oct; 130():231-243. PubMed ID: 27390013
[TBL] [Abstract][Full Text] [Related]
3. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection.
Li F; Ploch S; Fast D; Michael S
J Mass Spectrom; 2012 May; 47(5):655-67. PubMed ID: 22576879
[TBL] [Abstract][Full Text] [Related]
4. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.
Capiau S; Veenhof H; Koster RA; Bergqvist Y; Boettcher M; Halmingh O; Keevil BG; Koch BCP; Linden R; Pistos C; Stolk LM; Touw DJ; Stove CP; Alffenaar JC
Ther Drug Monit; 2019 Aug; 41(4):409-430. PubMed ID: 31268966
[TBL] [Abstract][Full Text] [Related]
5. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and obstacles for microsampling techniques in bioanalysis: Special focus on DBS and VAMS.
Londhe V; Rajadhyaksha M
J Pharm Biomed Anal; 2020 Apr; 182():113102. PubMed ID: 32014628
[TBL] [Abstract][Full Text] [Related]
7. Dried Blood Spots-A Platform for Therapeutic Drug Monitoring (TDM) and Drug/Disease Response Monitoring (DRM).
Zailani NNB; Ho PC
Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):467-494. PubMed ID: 37495930
[TBL] [Abstract][Full Text] [Related]
8. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients.
Mercolini L; Mandrioli R; Protti M; Conca A; Albers LJ; Raggi MA
Bioanalysis; 2014 Jun; 6(11):1487-95. PubMed ID: 25046049
[TBL] [Abstract][Full Text] [Related]
9. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
Protti M; Catapano MC; Samolsky Dekel BG; Rudge J; Gerra G; Somaini L; Mandrioli R; Mercolini L
J Pharm Biomed Anal; 2018 Apr; 152():204-214. PubMed ID: 29414014
[TBL] [Abstract][Full Text] [Related]
10. Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring.
Antunes MV; Charão MF; Linden R
Clin Biochem; 2016 Sep; 49(13-14):1035-46. PubMed ID: 27179588
[TBL] [Abstract][Full Text] [Related]
11. Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities.
Müller IR; Linden G; Charão MF; Antunes MV; Linden R
Expert Rev Clin Pharmacol; 2023; 16(8):691-701. PubMed ID: 37300458
[TBL] [Abstract][Full Text] [Related]
12. Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples.
Hofman S; Bolhuis MS; Koster RA; Akkerman OW; van Assen S; Stove C; Alffenaar JW
Bioanalysis; 2015; 7(4):481-95. PubMed ID: 25747766
[TBL] [Abstract][Full Text] [Related]
13. Dried blood spots in toxicology: from the cradle to the grave?
Stove CP; Ingels AS; De Kesel PM; Lambert WE
Crit Rev Toxicol; 2012 Mar; 42(3):230-43. PubMed ID: 22348353
[TBL] [Abstract][Full Text] [Related]
14. Emerging liquid chromatography-mass spectrometry technologies improving dried blood spot analysis.
Rao RN
Expert Rev Proteomics; 2014 Aug; 11(4):425-30. PubMed ID: 24697571
[TBL] [Abstract][Full Text] [Related]
15. LC-MS/MS bioanalysis of loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study.
Li W; Doherty J; Moench P; Flarakos J; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():117-24. PubMed ID: 25645810
[TBL] [Abstract][Full Text] [Related]
16. Analysis of dried blood spots using DESI mass spectrometry.
Wiseman JM; Kennedy JH
Methods Mol Biol; 2014; 1198():291-7. PubMed ID: 25270937
[TBL] [Abstract][Full Text] [Related]
17. What is next for dried blood spots?
Ji QC; Liu G; D'Arienzo CJ; Olah TV; Arnold ME
Bioanalysis; 2012 Aug; 4(16):2059-65. PubMed ID: 22946921
[TBL] [Abstract][Full Text] [Related]
18. Preanalytical considerations in therapeutic drug monitoring of immunosuppressants with dried blood spots.
Klak A; Pauwels S; Vermeersch P
Diagnosis (Berl); 2019 Mar; 6(1):57-68. PubMed ID: 30808156
[TBL] [Abstract][Full Text] [Related]
19. Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations.
Bian S; Van den Berghe N; Vandersmissen L; Tops S; Vermeire S; Ferrante M; Gils A; Thomas D
J Pharm Biomed Anal; 2020 Jun; 185():113224. PubMed ID: 32151929
[TBL] [Abstract][Full Text] [Related]
20. Adapting dried blood spot sampling for an anti-therapeutic antibody immunogenicity assay.
Xiang Y; Welch M; Amaravadi L; Stebbins C
J Immunol Methods; 2013 Jul; 393(1-2):53-60. PubMed ID: 23603618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
